Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, ...

Clinical research company IQVIA (NYSE: IQV) in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand ...

IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 12.3% in the 4th quarter, according to the company in its most recent ...

Baird raised the firm’s price target on Iqvia (IQV) to $220 from $210 and keeps a Neutral rating on the shares. The firm updated its model ...

DAVENPORT & Co LLC lowered its position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 88.4% during the 4th quarter, ...

Deutsche Bank raised the firm’s price target on Iqvia (IQV) to $260 from $250 and keeps a Buy rating on the shares following the “solid” Q4 ...

Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.

IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and ...

Shares of IQVIA Holdings Inc. IQV rallied 2.20% to $209.96 Thursday, on what proved to be an all-around mixed trading session ...

Clinical research company IQVIA (NYSE: IQV) will be announcing earnings results tomorrow before market hours. Here’s what to ...

IQVIA Holdings Inc (IQV) reports robust financial performance with record free cash flow and strategic partnership renewals, ...